93 related articles for article (PubMed ID: 29353143)
1. Contractile effect of rifaximin on bovine uterus in the presence of steroid hormone antagonists.
Sciorsci RL; Piccinno M; Rizzo A
Theriogenology; 2018 Apr; 110():74-78. PubMed ID: 29353143
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of three antibiotics on uterus bovine contractility in vitro and likely therapeutic approaches in reproduction.
Piccinno M; Rizzo A; Maselli MA; Derosa M; Sciorsci RL
Theriogenology; 2014 Dec; 82(9):1287-95. PubMed ID: 25263483
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin plus antibiotics: A synergism of potentiation to enhance bovine uterine contractility.
Piccinno M; Rizzo A; Cariello G; Staffieri F; Sciorsci RL
Theriogenology; 2016 Sep; 86(5):1203-11. PubMed ID: 27173953
[TBL] [Abstract][Full Text] [Related]
4. Modulation of oestrogenic effects by progesterone antagonists in the rat uterus.
Chwalisz K; Stöckemann K; Fritzemeier KH; Fuhrmann U
Hum Reprod Update; 1998; 4(5):570-83. PubMed ID: 10027611
[TBL] [Abstract][Full Text] [Related]
5. Effects of d-cloprostenol on different layers and regions of the bovine uterus during the follicular and luteal phases.
Piccinno M; Sciorsci RL; Masciopinto V; De Rosa M; Rizzo A
Theriogenology; 2017 Jul; 96():92-96. PubMed ID: 28532844
[TBL] [Abstract][Full Text] [Related]
6. The influence of estrogens, progesterone and their antagonists on the collagen content in the pregnant rat uterus.
Bieńkiewicz A; Welfel J; Kuś E
Horm Metab Res; 1996 Nov; 28(11):592-4. PubMed ID: 8960899
[TBL] [Abstract][Full Text] [Related]
7. The effect of GnRH on in vitro bovine myometrial activity.
Giammarino A; Manera M; Robbe D; Perugini M; Amorena M
Anim Reprod Sci; 2009 Jun; 112(3-4):325-33. PubMed ID: 18579322
[TBL] [Abstract][Full Text] [Related]
8. Regulation of non-pregnant human uterine contractility. Effect of antihormones.
Gemzell K; Swahn ML; Bygdeman M
Contraception; 1990 Sep; 42(3):323-35. PubMed ID: 2289392
[TBL] [Abstract][Full Text] [Related]
9. Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancy.
Perusquía M; Espinoza J; Navarrete E
Steroids; 2009 Oct; 74(10-11):825-31. PubMed ID: 19464306
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of mifepristone-induced spasmolytic effect on isolated rat uterus.
Parra J; Cantabrana B; Hidalgo A
Life Sci; 2000 May; 66(26):2563-9. PubMed ID: 10883734
[TBL] [Abstract][Full Text] [Related]
11. Effect of mifepristone on steroid receptor expression and biotransformation of oestrogen and progesterone in rat uterus and deciduoma.
Vij U; Kumar A; Sharma K; Kaushal M; Mehra R
Natl Med J India; 2006; 19(2):64-9. PubMed ID: 16756191
[TBL] [Abstract][Full Text] [Related]
12. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
Kraus WL; Katzenellenbogen BS
Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
[TBL] [Abstract][Full Text] [Related]
13. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
14. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
15. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
Mäentausta O; Svalander P; Danielsson KG; Bygdeman M; Vihko R
J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465
[TBL] [Abstract][Full Text] [Related]
16. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
Thota C; Gangula PR; Dong YL; Yallampalli C
Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
[TBL] [Abstract][Full Text] [Related]
17. Effect of neonatal treatment with mifepristone or tamoxifen on the binding capacity of the thymic glucocorticoid or uterine estrogen receptor of adult rats: data on the mechanism of hormonal imprinting.
Csaba G; Inczefi-Gonda A
Life Sci; 2000 Oct; 67(20):2531-7. PubMed ID: 11065175
[TBL] [Abstract][Full Text] [Related]
18. Uterine epithelial morphology and progesterone receptors in a mifepristone-treated viviparous lizard Pseudemoia entrecasteauxii (Squamata: Scincidae) during gestation.
Biazik JM; Parker SL; Murphy CR; Thompson MB
J Exp Zool B Mol Dev Evol; 2012 Mar; 318(2):148-58. PubMed ID: 22532476
[TBL] [Abstract][Full Text] [Related]
19. The effect of mepyramine and ranitidine on the oestrogen and anti-oestrogen stimulated rat uterus.
Marshall K; Senior J
Br J Pharmacol; 1986 Sep; 89(1):251-6. PubMed ID: 3801774
[TBL] [Abstract][Full Text] [Related]
20. Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
Sant'Anna GDS; Brum IS; Branchini G; Pizzolato LS; Capp E; Corleta HVE
Gynecol Endocrinol; 2017 Aug; 33(8):629-633. PubMed ID: 28300476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
